Paricalcitol
Paricalcitol is listed in the FDA National Drug Code directory with 46 NDC codes, marketed under brand names including Paricalcitol, Zemplar. Available dosage forms: injection, solution, capsule, liquid filled, injection, capsule, powder.
Drug Details
- Generic Name
- Paricalcitol
- Brand Names
- Paricalcitol, Zemplar
- Application Number
- NDA207174
- Sponsor
- Accord Healthcare, Inc.
- NDC Codes
- 46
- Dosage Forms
- INJECTION, SOLUTION, CAPSULE, LIQUID FILLED, INJECTION, CAPSULE, POWDER
- Routes
- INTRAVENOUS, ORAL
- Active Ingredients
- PARICALCITOL
Indications and Usage
1 INDICATIONS AND USAGE Paricalcitol Injection is indicated for the prevention and treatment of secondary hyperparathyroidism in patients 5 years of age and older with chronic kidney disease (CKD) on dialysis. Paricalcitol Injection is a vitamin D analog indicated for the prevention and treatment of secondary hyperparathyroidism in patients 5 years of age and older with chronic kidney disease on dialysis.